pirlindole

monoamine oxidase A ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29221756 Characterization of the binding site for d-deprenyl in human inflamed synovial membrane. 2018 Feb 1 1
2 21075154 Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. 2011 Jan 1
3 21877764 Pirlindole in the treatment of depression and fibromyalgia syndrome. 2011 Oct 1 1
4 15056494 Conformational changes in monoamine oxidase A in response to ligand binding or reduction. 2004 Apr 7 1
5 12679138 Pre- and post-treatment with pirlindole and dehydropirlindole protects cultured brain cells against nitric oxide-induced death. 2003 Apr 11 1
6 12781338 Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure. 2003 Jun 1 2
7 11061215 Selective inhibitors and computer modelling of the active site of monoamine oxidase. 2000 2
8 10591049 Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis. 1999 1
9 9564636 The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding. 1998 1
10 9703624 [Level of monoamines during hypobaric hypoxia and protective effect of pyrazidol]. 1998 May-Jun 1
11 9272198 Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression. 1997 Aug 2
12 8953568 Effects of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase-A and on GABAA receptors. 1996 Dec 1
13 9020990 A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression. 1996 Dec 2
14 6649522 [Selective inhibition by pyrazidol of monoamine oxidase type A in different human and animal tissues]. 1983 Sep-Oct 1